ME1 — Melodiol Global Health Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- AU$0.01m
- AU$8.96m
- AU$19.60m
Annual income statement for Melodiol Global Health, fiscal year end - December 31st, AUD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 3.68 | 2.45 | 6.22 | 6.32 | 19.6 |
| Cost of Revenue | |||||
| Gross Profit | 1.68 | 0.145 | — | -0.545 | 3.01 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 19 | 33.2 | 36.2 | 27.9 | 46.4 |
| Operating Profit | -15.3 | -30.8 | -30 | -21.6 | -26.8 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -15.3 | -30.8 | -30 | -21.9 | -35.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -15.3 | -30.8 | -30 | -21.9 | -35.5 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -15.1 | -30.8 | -30 | -32.8 | -52.4 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -15.1 | -30.8 | -30 | -32.8 | -52.4 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -52.2 | -33.1 | -14.8 | -7.3 | -6.17 |